CareDx, Inc
CDNA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $100 | $87 | $85 | $87 |
| % Growth | 15.4% | 2.4% | -2.2% | – |
| Cost of Goods Sold | $31 | $29 | $28 | $28 |
| Gross Profit | $69 | $58 | $56 | $58 |
| % Margin | 68.7% | 66.9% | 66.4% | 67.5% |
| R&D Expenses | $17 | $17 | $19 | $17 |
| G&A Expenses | $28 | $28 | $23 | $41 |
| SG&A Expenses | $53 | $52 | $46 | $62 |
| Sales & Mktg Exp. | $24 | $24 | $23 | $21 |
| Other Operating Expenses | -$3 | $0 | $5 | -$95 |
| Operating Expenses | $67 | $69 | $70 | -$16 |
| Operating Income | $2 | -$11 | -$13 | $75 |
| % Margin | 2% | -12.8% | -15.8% | 86.3% |
| Other Income/Exp. Net | -$0 | $2 | $3 | $3 |
| Pre-Tax Income | $2 | -$9 | -$10 | $78 |
| Tax Expense | -$0 | -$0 | $0 | $0 |
| Net Income | $2 | -$9 | -$10 | $78 |
| % Margin | 1.7% | -9.9% | -12.2% | 90.1% |
| EPS | 0.03 | -0.16 | -0.19 | 1.62 |
| % Growth | 118.8% | 15.8% | -111.7% | – |
| EPS Diluted | 0.03 | -0.16 | -0.19 | 1.51 |
| Weighted Avg Shares Out | 53 | 54 | 55 | 54 |
| Weighted Avg Shares Out Dil | 54 | 54 | 55 | 58 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $2 | $3 | $3 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $5 | $5 | $5 | $5 |
| EBITDA | $7 | -$6 | -$3 | -$15 |
| % Margin | 6.8% | -6.6% | -3.6% | -17.6% |